Growth Metrics

QuidelOrtho (QDEL) Short-Term Debt repayments (2025 - 2026)

QuidelOrtho recorded quarterly Short-Term Debt repayments of $45.0 million in Q1 2026, down 55.0% quarter-over-quarter from $100.0 million in Q4 2025.

QuidelOrtho's Short-Term Debt repayments history runs 2 years deep, the most recent figure standing at $45.0 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt repayments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 259.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 QuidelOrtho 898.19 Mn 757.79 Mn - 45.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 45.00 Mn
Mar 29, 2026 45.00 Mn
Dec 28, 2025 100.00 Mn
Dec 28, 2025 100.00 Mn